Long‐Term Impact of Belimumab on Health‐Related Quality of Life and Fatigue in Patients With Systemic Lupus Erythematosus: Six Years of Treatment

OBJECTIVE: To report long‐term health‐related quality of life (HRQoL) and fatigue outcomes in patients with systemic lupus erythematosus (SLE) receiving belimumab. METHODS: Patients with SLE who completed the Study of Belimumab in Subjects with SLE 76‐week trial (BLISS‐76) were enrolled in this cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Strand, Vibeke, Berry, Pamela, Lin, Xiwu, Asukai, Yumi, Punwaney, Rajesh, Ramachandran, Sulabha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Systemic Lupus Erythematosus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593666/
https://www.ncbi.nlm.nih.gov/pubmed/30320964
http://dx.doi.org/10.1002/acr.23788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593666/
https://www.ncbi.nlm.nih.gov/pubmed/30320964
http://dx.doi.org/10.1002/acr.23788

Ejemplares similares